Clincosm LogoSign in Get a demo

StemiLor: Acute Coronary Syndome With ST Elevation in Northern Lorraine

Sponsor
Centre Hospitalier Régional Metz-Thionville (Other)
Overall Status
Completed
CT.gov ID
NCT03355898
Collaborator
(none)
340
Enrollment
3
Actual Duration (Months)

Study Details

Study Description

Brief Summary

Lorraine is one of the most affected French region by cardiovascular diseases with a mortality rate for ischemic heart disease higher than the national average in 2010. Due to practice change with the new recommandations of the European Society of Cardiology involving the myocardic revascularization, the investigators wanted to compare the Stemi care in 2005-2006, 2010-2011 and 2015 in the CHR Metz-Thionville.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This monocentric study evaluate the impact of the new recommandations of the European Society of Cardiology in the acute coronary syndrome with ST elevation (Stemi) care. Data is compiled retrospectively from angiographic report and informatic medical record.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    340 participants
    Observational Model:
    Other
    Time Perspective:
    Retrospective
    Official Title:
    Acute Coronary Syndrome With ST Elevation in Northern Lorraine: Evolution of Clinicals, Epidemiological and Angiographic Data Since 2005
    Actual Study Start Date :
    Mar 1, 2016
    Actual Primary Completion Date :
    Apr 1, 2016
    Actual Study Completion Date :
    Jun 1, 2016

    Outcome Measures

    Primary Outcome Measures

    1. Acute coronary syndrome with ST elevation care [Day 1]

      Percentage of per-cutaneous angioplasty and percentage of pre-hospital thrombolysis

    Secondary Outcome Measures

    1. Stenting procedure [Day 1]

      Percentage of manual thrombectomy and percentage of direct stenting

    2. Hospital mortality [Day 1]

      Percentage of death during the STEMI care

    3. Epidemiology data [Day 1]

      Mean age of STEMI patients

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Patient with an acute coronary syndrome with ST elevation for less than 12 hours

    • Patients with coronarography in a context of cardiorespiratory arrest with unknown cause and acute coronary occlusion

    Exclusion Criteria:

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Centre Hospitalier Régional Metz-Thionville

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Centre Hospitalier Régional Metz-Thionville
    ClinicalTrials.gov Identifier:
    NCT03355898
    Other Study ID Numbers:
    • 2016-06Obs-CHRMT
    First Posted:
    Nov 28, 2017
    Last Update Posted:
    Nov 30, 2017
    Last Verified:
    Nov 1, 2017
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Acute Coronary Syndrome
    Syndrome

    Study Results

    No Results Posted as of Nov 30, 2017